Influx HealthtechNSE:INFLUX -1.50%21 Interest Coverage is 71.51 as of Mar. 2026, which is 93% below its 10-year median of 1,022.04. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 685 Drug Manufacturers companies, Influx Healthtech ranks better than 82.77% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Influx Healthtech's
Operating Income
for the
six
months ended in Mar. 2026 was ₹131 Mil. Influx Healthtech's Interest Expense for the
six
months ended in Mar. 2026 was ₹-2 Mil.
Influx Healthtech's interest coverage for the quarter that ended in Mar. 2026 was 71.51.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Influx Healthtech Ltd has no debt.
The historical rank and industry rank for Influx Healthtech's Interest Coverage or its related term are showing as below:
NSE:INFLUX'
s Interest Coverage Range Over the Past 10 Years
Min: 88.4 Med: 1022.04 Max: 19886.89
Current: 141.58
NSE:INFLUX's Interest Coverage is ranked better than 82.77% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs NSE:INFLUX: 141.58
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Influx Healthtech Interest Coverage Related Terms
Influx Healthtech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Influx Healthtech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
NSE:INFLUX vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Influx Healthtech Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Influx Healthtech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Influx Healthtech (NSE:INFLUX) has a Interest Coverage of 71.51 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Influx Healthtech and its competitors. This is 93% below median its historical median of 1,022.04. Over the past decade, Influx Healthtech's Interest Coverage has ranged from 88.40 to 19,886.89. According to the industry distribution chart, Influx Healthtech ranks #118 out of 685 companies in the Drug Manufacturers industry, placing it in the top 17.2%.
Is Influx Healthtech's Interest Coverage too high?
Influx Healthtech's current Interest Coverage of 71.51 is 93% below median its 10-year median of 1,022.04. Over the past 10 years, this metric has ranged from a low of 88.40 to a high of 19,886.89. The Drug Manufacturers industry median Interest Coverage is 12.75. Influx Healthtech's value of 71.51 is 460.9% above this industry median. Based on the distribution chart, Influx Healthtech ranks #118 out of 685 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #118 out of 685 companies for Interest Coverage. This places Influx Healthtech in the top 17% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Influx Healthtech's value of 71.51 is 460.9% above this benchmark. Historically, Influx Healthtech's own Interest Coverage has ranged from 88.40 to 19,886.89 over the past decade. While the company's 10-year median is 1,022.04 vs. the industry median of 12.75, Influx Healthtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Influx Healthtech's current Interest Coverage of 71.51 is 460.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Influx Healthtech and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Influx Healthtech's current Interest Coverage is 71.51, which is 93% below median its own 10-year median of 1,022.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Interest Coverage of 71.51. The current Interest Coverage is 71.51, which is 93% below median its 10-year median of 1,022.04 and 460.9% above the Drug Manufacturers industry median of 12.75. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Interest Coverage is 71.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score
Get the complete analysis for NSE:INFLUX
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFLUX has been successfully added to your 